Cell-based multi-target QSAR model for design of virtual versatile inhibitors of liver cancer cell lines

• Published in: SAR and QSAR in environmental research Vol. 31; no. 11; pp. 815 - 836
• Main Authors: Kleandrova, V.V., Scotti, M.T., Scotti, L., Nayarisseri, A., Speck-Planche, A.
• Format: Journal Article
• Language: English
• Published: Abingdon Taylor & Francis 01.11.2020; Taylor & Francis Ltd
• Subjects: Anticancer; Anticancer properties; Antitumor agents; artificial neural network; Biotechnology; Design; Drug development; fragment; Fragments; Hepatocytes; Liver; Liver cancer; multi-target; Neoplasms; QSAR; Structure-activity relationships; Tumor cell lines; virtual design
• ISSN: 1062-936X; 1029-046X; 1029-046X
• DOI: 10.1080/1062936X.2020.1818617

Liver cancers are one of the leading fatal diseases among malignant neoplasms. Current chemotherapeutic treatments used to fight these illnesses have become less efficient in terms of both efficacy and safety. Therefore, there is a great need of search for new anti-liver cancer agents and this can be accelerated by using computer-aided drug discovery approaches. In this work, we report the development of the first cell-based multi-target model based on quantitative structure-activity relationships (CBMT-QSAR) for the design and prediction of chemicals as anticancer agents against 17 liver cancer cell lines. While having a good quality and predictive power (accuracy higher than 80%) in the training and test sets, respectively, the CBMT-QSAR model was employed as a tool to directly extract suitable fragments from the physicochemical and structural interpretations of the molecular descriptors. Some of these desirable fragments were assembled, leading to the virtual design of eight molecules with drug-like properties, with six of them being predicted as versatile anticancer agents against the 17 liver cancer cell lines reported here.